Literature DB >> 17272308

Gene expression analysis during tumor enhancement by the dietary phytochemical, 3,3'-diindolylmethane, in rainbow trout.

Susan C Tilton1, Jerry D Hendricks, Gayle A Orner, Cliff B Pereira, George S Bailey, David E Williams.   

Abstract

Indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM), a primary I3C derivative, are known dietary chemopreventive agents also available as supplements. However, I3C has been found to act as a tumor promoter in rat (multi-organ) and trout (liver) models. I3C and DIM were previously found to be estrogenic in trout liver based on toxicogenomic profiles. In this study, we compare the post-initiation effects of DIM and 17beta-estradiol (E2) on aflatoxin B(1) (AFB(1))-induced hepatocarcinogenesis in trout. Trout were initiated as embryos with AFB(1) and juvenile fish were fed diets containing 0, 120 or 400 p.p.m. DIM or 5 p.p.m. E2 for 18 weeks. Tumor incidence was determined at 13 months and found to be significantly elevated in AFB(1)-initiated trout fed either 400 p.p.m. DIM or 5 p.p.m. E2 compared with control animals. To evaluate the mechanism of tumor enhancement, hepatic gene expression profiles were examined in animals fed promotional diets during the course of tumorigenesis and in hepatocellular carcinomas (HCCs) of initiated animals. We demonstrate that DIM alters gene expression profiles similar to E2 in liver samples during tumorigenesis and in HCC tumors. Further, HCCs from animals on DIM and E2 promotional diets had a transcriptional signature indicating decreased invasive or metastatic potential compared with HCCs from control animals. Overall, these findings are the first to demonstrate tumor promotion by DIM. They confirm the importance of estrogenic signaling in the mechanism of promotion by dietary indoles in trout liver and indicate a possible dual effect that enhances tumor incidence and decreases potential for metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17272308     DOI: 10.1093/carcin/bgm017

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

Review 1.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

2.  Transcriptional changes in innate immunity genes in head kidneys from Aeromonas salmonicida-challenged rainbow trout fed a mixture of polycyclic aromatic hydrocarbons.

Authors:  Lawrence R Curtis; Claudia F Bravo; Christopher J Bayne; Fred Tilton; Mary R Arkoosh; Elisabetta Lambertini; Frank J Loge; Tracy K Collier; James P Meador; Susan C Tilton
Journal:  Ecotoxicol Environ Saf       Date:  2017-04-11       Impact factor: 6.291

3.  Rainbow trout (Oncorhynchus mykiss) and ultra-low dose cancer studies.

Authors:  David E Williams; Gayle Orner; Kristin D Willard; Susan Tilton; Jerry D Hendricks; Clifford Pereira; Abby D Benninghoff; George S Bailey
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-12-13       Impact factor: 3.228

4.  Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3'-diindolylmethane in healthy subjects.

Authors:  Gregory A Reed; Jean M Sunega; Debra K Sullivan; John C Gray; Matthew S Mayo; James A Crowell; Aryeh Hurwitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

Review 5.  DNA Microarray-Based Screening and  Characterization of Traditional Chinese Medicine.

Authors:  Ryoiti Kiyama
Journal:  Microarrays (Basel)       Date:  2017-01-30

6.  Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout.

Authors:  Susan C Tilton; Gayle A Orner; Abby D Benninghoff; Hillary M Carpenter; Jerry D Hendricks; Cliff B Pereira; David E Williams
Journal:  Environ Health Perspect       Date:  2008-08       Impact factor: 9.031

Review 7.  Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal Cancer.

Authors:  Soo Mi Kim
Journal:  Int J Mol Sci       Date:  2016-07-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.